Correlating Antiretroviral Therapy Adherence and Detection of HIV Viral Loads at Chitipa District Hospital


  • Sekani C. Mkwala Bachelor’s Degree in Biomedical Sciences, Mzuzu University, Mzuzu, P /bag 201, Malawi
  • Felix Dambula MSc. Molecular biology, BSBS, Lecturer in Biomedical Sciences, Mzuzu University, Mzuzu, P/bag 201, Malawi


Poor ART adherence, detectable HIV viral load, HIV drug resistance strains


HIV infection remains an epidemic threat around the world mostly prevalent in developing countries especially in sub- Sahara African region where many cultural practices and beliefs aggravate the transmission of HIV/AIDS. Poor Antiretroviral therapy (ART) adherence remains a big challenge leading to persistence detection of high HIV viral load results which deteriorate PLHIV health through lowering immunity [1]. This study aimed to determine the correlation of ART adherence with high detection of viral load levels among HIV patients receiving ART at Umoyo ART clinic (Chitipa DHO) in Chitipa district. A retrospective study design using PLHIV records, on HIV viral load results in viral register and ART adherence percentage (based on number of days missed to collect ARV drugs) using Electronic Medical Records (EMR) system between January, 2018 and December, 2018. There were 3890 patients registered alive on ART but 2835 patients had their viral load results in register.  Therefore, 351 sample records were extracted using systematic sampling technique and analysed using statistical package for social sciences (SPSS) version 20. The findings showed that 37.7% (n=131) of HIV patients in the study had detectable viral load after a duration of over six months on ART and more experienced in 80/200 (42%) of patients with good adherence. However, poor ART adherence (?95%) more prevalent in men, youths and HIV patients less than five years on ART. Pearson’s Chi square test indicated a statistical significant on correlation between age and ART adherence as well as ART adherence and HIV viral load results (p<0.05). On the other hand, gender and duration on ART were not significant to ART adherence level. Eventually, it is recommended more ART clerks should be recruited so that any HIV individual initiated on ART should intensively counselled on poor ART adherence which may lead to development of HIV drug resistance strains that need expensive second and third line regimen ARV drugs.


MOH. Malawi integrated guideline for providing health services. 1st Ed. Lilongwe, Malawi: Department for HIV and AIDS, 2011.

A. Amberbir, K. Woldemichael, S. Gatechews, B. Girma and K. Deribe. (2008, Jul.). ''predicators of adherence of antiretroviral therapy among HIV -infected persons: Prospective study in Southwest Ethiopia". BMC Public Health. [on- line]. vol. 8. p. 265. Available: [Nov. 25, 2018].

GBD 2015 collaborators. "Estimates of global, region and national incidence, prevailance and mortality of HIV 1980-2015 : The global burden of disease study 2015." The Lancet of HIV, pp. 361-87, Aug, 2016.

J. Dorward, J. Quame-Amaglo, N. Garrent, N. Samsunder, H. Ngobese, M. Ngomane, & P. K. Drain. (2017, Aug.). "protocal for a randomised controlled implementation trial of point -of -care viral load testing and task shifting: the simplified HIV treatment and monitoring (STREAM) study". BMJ open [on-line]. vol.7, pp, 1-7. available: doi:10.1136/bmjopen-2017-017507 [Nov.13, 2018].

WHO. HIV /AIDS programme, WHO HIV drug resistance report 2012. Geneva, Switzerland: WHO press, 2012.

A. Hardon, H. Irunde, J. Kglatwane, J. Kinsman, A. Nakiyemba, D. Akurut, & J. Maridadi. (2010, Sept.). "Hunger, Waiting time and transport costs : time to confront challenges to Antiretroviral therapy in Africa" HAL archives-ouvertes. [on- line]. 19 (5), pp. 658-65. available: [Mar. 4, 2019].

A. D. Harries, R. Zachariah, J. J. Van Oosterhout, S. D. Reid, M. C. Hosseinipour, & K. Kamoto. (2010, Jan.). "Diagnosis and management of antiretroviral -therapy failure in resource -limited settings in Sub-SAhara African: Callenges and prospectives." Lancet infectious diseases. [on- line]. 10(1). pp. 60-5. Available: doi: 10.1016/S1473-3099(09)70321-4. [Jan. 23, 2019].

R. L. Hamers. Drug resistance HIV-1 in Sub- Sahara Africa: Clinical Pulibc health studies. Amsterdam, Netherlands, 2013, pp.15-21.

E. Gardner, M. Mc Lees, J. Steiner C. Rio, & W. Burman. "Spectrum of Engagement in HIV care and its relevance to Test -and -treat Strategies for prevention of HIV infection." Journal of clinical infectious diseases, 52 (6), pp. 793-800, Jan. 2011.

WHO. Antiretroviral therapy for HIV infection in adults and adolescents , recommendations for a Public Health Approach, 2010 revision. Geneva, Switzerland: World Health Organisation, 2010.

K.C. Sigaloff, R. L. Hamers, C. L. Wallis, C. Kityo, M. Siwale, P. Ive, . . . M. Wellington. "Unnecessary Antiretroviral treatment switches and accumulation of HIV resistance mutation, two arguments for vira load monitoring in Africa." Journal of Acquired Immune Deficiency Syndrome, 58 (1), pp. 23-31, Feb. 2011.

MOH. Ministry of Health and population services, Malawi clinical HIV guidelines 2018. Lilongwe, Malawi: Department for HIV and AIDS -MOH, 2018, pp. 45-76.

M. Cauldbeck, C. O'Connor, M. O'Connor, J. Saunders, B. Rao, V. Mallesh, . . . G. Mamtha. (2009, Apr.). ''Adherence to antiretroviral therapy among HIV patients at Bangalore, India." AIDS research and therapy. [on- line], 6(7). Available: http: [Nov. 24, 2018].

B. A. Forbes, D. F. Sahm, & A. S. Weissfeld. Bailey and Scott`s Diagnostic microbiology. 12th Ed. Cannada, USA: Mosby. 2009, pp. 660-840.

W.H.O. Consolidated guideline on the use of antiretroviral drugs for treating and preventing HIV infection recommendations for a public health approach. Geneva 27, Switzerland: WHO press, 2016, pp. 243-58.

Teira, Vidal, Munoz-Sanchez, Geijo, Viciana, Ribera, . . . Martinez. (2017, Mar.). "Very low level viraemia and risk of virological failure in a treated HIV-1-infected patients." VACH STUDY GROUP. [on- line]. 18(3), pp.196-203. Available: doi: 10.1111/hiv.12413. [Jan. 23, 2018].

Malawi/ AVERT. (2018, Dec. 10.). "HIV and AIDS in Malawi." Internet: -world-Sub- Sahara-Africa/Malawi, [ Jan. 21, 2019].

C. R. Kothari. Research methodology. Methods and techniques. Daryanganji, New Delhi: New age international, 2004.

V. Agrasula. The adoption of green dentistry among dentists in Thailand. Ministry of public health, Thailand, 2013.

M. Mugavero, K. Amico, A. Westfall, H. Crane, A. Zinski, J. Willig & M. Saag. (2012, Jan.). "Early retention in HIV Care and viral load suppression: implications for a test and treat approach to HIV prevention." Journal Acquired Immune Deficiency Syndrome, [on- line]. 59(1), pp. 86-93. Available: doi: 10.1097/QAI.0b013e318236f7d2. [Dec. 18, 2018].

K. C. Sigaloff, R. L Hamers, C. L. Wallis, C. Kityo, M. Siwale, P. Ive, . . . M. Wellington. "Second-line antiretroviral treatment successfully re-supresses drug resistant HIV-1 after first -line failure: Prospective cohort in Sub -Sahara Africa." Journal of Infectious Diseases, Mar. 2012.

J. Denison, O. Koole, S. Tsui, J. Menten, K. Tropey, E. Praag, . .A.F. Auld. (2015, Jun.). "Incomplete adherence among treatment -experienced adultson antiretroviral therapy in Tanzania, Uganda and Zambia."Journal on AIDS. [on- line]. 29(3), pp. 361-71. Available: DOI:10.1097/QAD.0000000000000543. [Mar. 04,2019].

J. E. Haberer, A. Cook, A. S. Walker, M. Nga`ambi, A. Ferrier, V. Mulenga, . . . M. Thomason. (2011, Apr.). "Excellent adherence to Antiretrovirals HIV + Zambians children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects." PLoS ONE, [on- line]. 6(4). Available: [Dec. 14, 2018].

L. Lynen, S. An, O. Koole, S. Ros, P. De Munter & R. Colebunders. "An algorithm to optimize viral load testing in HIV -positive patients with suspected of first - line antiretroviral therapy failure in Cambodia." JAIDS journal of Aquired Immune Deficiency Syndrome, 52 (1), pp 40-8, Sept. 2009.

S. M. McCluskey, Y. Boum, N. Musinguzi, J. N. Martin, P. W. Hunt, M. J. Siedner, & J. E. Haberer.(2017, Oct.). "A brief report: Appraising viral load thresholds and adherence support recommendations in the World Health Organisation guidelines for detection and management of viralogic failure." Journal of Acquired Immune Deficiency Syndrome. [on- line]. 76(2), pp. 183-7.Available: doi: 10.1097/QAI.0000000000001479. [Jan. 20, 2019].

D. Maman, B. Chilima, C. Masiku, A. Ayouba, S. Masson, E. Szumilin, M. Peeters, N. Ford, A. Heinzelmann,

B. Riche & J. Etard. (Feb. 2016). “Closer to 90–90–90. The cascade of care after 10 years of ART scale-up in rural Malawi: a population study.” J Int AIDS Soc. [on- line]. Available: doi: 10.7448/IAS.19.1.20673. [Nov. 11, 2018].

M. Kim, A. Mazenga, X. Yu, S. Ahmed, M. Paul, P. Kazembe & E. Abrams. (2017, Mar.). "High self reported non Adherence to antiretroviral therapy amongst adolescents living with HIV in Malawi : Barriers and associated factors." Journal of the International AIDS Society. [on- line]. Vol. 20. Available: [Dec. 05, 2018].

L. Li, S. Lee, Y. Wen, C. Lin, D. Wan, & C. Jiraphongsa. (2010, Jun.) "Antiretroviral therapy adherence among patients living with HIV/AIDS in Thailand." Nursing and Health sciences. [on- line]. 12(2), pp. 212-20. Available: DOI: 10.1111/j.1442-2018.2010.00521.x. [Mar. 04, 2019].

S. Wasti, P. Simkhada, J. Randall, J. Freeman, & E. Teijlingen. (2012, Apr.). "Factors influencing adherence to antiretroviral treatment in Nepa: A mixed - Methods study." PLoS ONE. 7(5). Available: doi:10.1371/journal.pone.0035547. [Dec. 04, 2018].

V. Bhat, M. Ramburuth, M. Singh, O. Titi, A. Anthony, L. Chiya . . . M.E. Mofoka. "Factors associated with poor adherence to antiretroviral therapy in patients attendinga rural health centre in South Africa". European Journal of clinical microbiology and infectious diseases, 29(8), pp. 947-53, 2010.

S. Chen, J. K. Yu, A. D. Harries, C. N. Bong, R. Kalola- Dzimadzi, T. S. Tok & J. Wang. (2008, Mar.10). “Increased mortality of male adults with AIDS related to poor compliance to antiretroviral therapy in Malawi.” Tropical Medicine & International Health [on- line]. Available: [Nov. 23, 2018].

C. Protopopescu, B. Spire, M. P. Carrieri, C. Leport, F. Raffi, P. Roux, . . . P. Dellamonica. (2009, Jul.). "Factors associated with non-adherence to long term high antiretroviral therapy: a 10 year follow -up analysis with correction for the bias induced by missing data." Journal of Antimicrobial Chemotherapy. [on- line]. vol.64, pp. 599-606. Available: doi:10.1093/jac/dkp232. [Nov. 23, 2018].

E. Kang, D. A. Delzell, M. Chhabra & P. Oberdorfer. "Factors associated with high rates of antiretroviral medication adherence among young living with perinatal HIV in Thailand." International Journal of STD AIDS, 26 (8), pp. 334-41, Mar. 2015.




How to Cite

Mkwala, S. C. ., & Dambula, F. . (2019). Correlating Antiretroviral Therapy Adherence and Detection of HIV Viral Loads at Chitipa District Hospital. American Scientific Research Journal for Engineering, Technology, and Sciences, 61(1), 13–28. Retrieved from